Literature DB >> 1802022

A novel in vitro chemosensitivity test using materials collected by endoscopic biopsy.

T Hirai1, K Kawano, N Hirabayashi, M Nishiyama, Y Yamashita, H Mukaida, T Iwata, T Toge.   

Abstract

The usefulness of chemosensitivity testing of cells collected by endoscopic biopsy using the adenosine triphosphate assay (ATP assay) was investigated for esophageal tumors. Correlation between this chemosensitivity test and other chemosensitivity tests was more than 80% in most combinations. The predictive rate of clinical sensitivity was 77.8% and of clinical resistance was 68.8%. The predictive accuracy was 72.0%. These results will extend the indication and usefulness of chemosensitivity testing in inoperable and preoperable cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1802022     DOI: 10.1097/00001813-199106000-00008

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  4 in total

1.  The slow cell death response when screening chemotherapeutic agents.

Authors:  Joseph Blois; Adam Smith; Lee Josephson
Journal:  Cancer Chemother Pharmacol       Date:  2010-12-31       Impact factor: 3.333

2.  Clinical usefulness of an ATP heat sensitivity test using endoscopic biopsy materials from esophageal cancer patients.

Authors:  T Hirai; T Iwata; N Hirabayashi; Y Yamashita; A Yoshimoto; K Noma; T Toge
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

3.  Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assay.

Authors:  O R Koechli; B U Sevin; J P Perras; T C Chou; R Angioli; A Steren; M Untch; H E Averette
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

Review 4.  Prediction of Cancer Drug Resistance and Implications for Personalized Medicine.

Authors:  Manfred Volm; Thomas Efferth
Journal:  Front Oncol       Date:  2015-12-17       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.